Description

Benzamide, n-(5,6-Dihydro-4H-Cyclopentathiazol-2-Yl)-4-Methyl- (9Ci) is a specialized organic compound featuring a benzamide core fused with a dihydrocyclopentathiazole moiety, making it a valuable advanced pharmaceutical intermediate for modern drug discovery. Its unique heterocyclic structure is critical for synthesizing novel bioactive molecules targeting a range of therapeutic areas. This high-purity intermediate is essential for research institutions, CROs/CDMOs, and pharmaceutical companies engaged in developing new chemical entities, particularly in medicinal chemistry programs.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, inflammation, or metabolic diseases.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop compounds with improved potency and selectivity.
• Heterocyclic Chemistry Synthesis: Acts as a precursor for constructing complex fused-ring systems common in many active pharmaceutical ingredients (APIs).
• Agrochemical Research: Potential application as an intermediate in the development of new crop protection agents and pesticides due to its bioactive scaffold.
• Biochemical Tool Compound: Can be utilized in biochemical assays to study enzyme inhibition or receptor-ligand interactions in early-stage discovery.
• Custom Synthesis & Scale-Up: A critical material for contract research and manufacturing organizations (CROs/CDMOs) offering custom synthesis services from milligram to kilogram scale.

Basic Information

Product Name	Benzamide, n-(5,6-Dihydro-4H-Cyclopentathiazol-2-Yl)-4-Methyl- (9Ci)
CAS No.	600129-18-8
Molecular Formula	C14H14N2OS
Molecular Weight	258.34 g/mol
Synonyms	4-Methyl-N-(5,6-dihydro-4H-cyclopenta[d]thiazol-2-yl)benzamide; N-(5,6-Dihydro-4H-cyclopenta[d]thiazol-2-yl)-4-methylbenzamide; 4-Methyl-N-(4,5,6,7-tetrahydro-1-benzothiazol-2-yl)benzamide; 2-(4-Methylbenzamido)-4,5,6,7-tetrahydro-1-benzothiazole; Benzamide, N-(5,6-dihydro-4H-cyclopenta[d]thiazol-2-yl)-4-methyl-; 600129-18-8; 4-Methylbenzoic acid (5,6-dihydro-4H-cyclopenta[d]thiazol-2-yl)amide
EINECS	Contact for details

Quality Control

Our Benzamide, n-(5,6-Dihydro-4H-Cyclopentathiazol-2-Yl)-4-Methyl- (9Ci) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment to support your quality assurance protocols and regulatory documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.